Literature DB >> 3490514

A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity.

G Antoni, R Presentini, F Perin, A Tagliabue, P Ghiara, S Censini, G Volpini, L Villa, D Boraschi.   

Abstract

Short peptide fragments of human and murine interleukin 1 (IL 1) were synthesized on the basis of their predicted exposure on the surface of the molecule in an attempt to identify the minimal structure responsible for the immunostimulatory activity of IL 1. One of these peptides, a fragment of nine residues of human IL 1 beta (VQGEESNDK, fragment 163-171), showed high T cell activation capacity, as judged by its ability to stimulate murine thymocyte proliferation and to potently induce interleukin 2 production in spleen cells. On the other hand, the 163-171 peptide was devoid of prostaglandin-inducing capacity in vitro and pyrogenic activity in vivo, two inflammatory features peculiar to the entire hu IL 1 beta molecule. Thus we propose that this peptide may represent one of the portions of hu IL 1 beta responsible for its immunostimulatory capacity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490514

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor.

Authors:  Margarida Borges; Anabela Cordeiro Da Silva; Denis Sereno; Ali Ouaissi
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  Bioactive peptides based on diversity libraries, supramolecular chemistry and rational design: a new class of peptide drugs. Introduction.

Authors:  Rob Meloen; Peter Timmerman; Hans Langedijk
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

3.  Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.

Authors:  Gregory Kanter; Junhao Yang; Alexei Voloshin; Shoshana Levy; James R Swartz; Ronald Levy
Journal:  Blood       Date:  2006-12-12       Impact factor: 22.113

4.  Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.

Authors:  P N Redlich; P D Hoeprich; C B Colby; S E Grossberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

5.  DNA fragment encoding human IL-1beta 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease.

Authors:  H J Shao; L Chen; Y B Su
Journal:  Vet Res Commun       Date:  2005-01       Impact factor: 2.459

6.  Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171.

Authors:  A E Postlethwaite; G N Smith; L B Lachman; R O Endres; H M Poppleton; K A Hasty; J M Seyer; A H Kang
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

7.  A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion.

Authors:  W J Britton; N Meadows; D A Rathjen; D R Roach; H Briscoe
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 8.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

9.  Characterization and mechanism of fever induction by interleukin-1 beta.

Authors:  M Hashimoto
Journal:  Pflugers Arch       Date:  1991-12       Impact factor: 3.657

10.  Human interleukin-1 induces a rapid relaxation of the rabbit isolated mesenteric artery.

Authors:  F Marceau; E Petitclerc; D DeBlois; P Pradelles; P E Poubelle
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.